Japanese Prime Minister Shinzo Abe’s recent visits to hospital have raised concern whether he will be able to stay on as leader of the world’s third-biggest economy until the Sept. 2021 end of his …
Pandemic may fire up Japan’s inflation, doing what cenbank could not, economist says
The coronavirus shock is boosting the amount of money flowing into Japan’s economy and may fire up inflation, achieving what years of ultra-loose monetary policy failed to do, the central bank’s …
Pandemic may fire up Japan’s inflation, doing what cenbank could not, economist says
The coronavirus shock is boosting the amount of money flowing into Japan’s economy and may fire up inflation, achieving what years of ultra-loose monetary policy failed to do, the central bank’s …
Japan and Myanmar agree to reopen borders for long-term residents
The foreign ministers of Japan and Myanmar agreed Monday to reopen borders for expatriates and other long-term residents as soon as early September, relaxi …
Stranded By Virus, Japan Couple Become Cape Verde Envoys
A pair of Japanese honeymooners stranded in Cape Verde by the coronavirus pandemic have been named unlikely ambassadors for the tropical paradise’s Olympic team at next year’s Tokyo Games. Rikiya and …
China Mengniu, Kirin Scrap Australia Deal Over Political Tension
China Mengniu Dairy Co. and Kirin Holdings Co. terminated their agreement for the purchase of the Japanese company’s Australian beverage unit amid strained relations between Sydney and Beijing.The ann …
Blackstone Makes $2.29 Billion Deal for Japan Drug Business
Blackstone Group is buying the consumer health-care business of Japan’s Takeda Pharmaceutical for $2.29 billion, one of the larger private-equity acquisitions in a country where such deals are slowly …
Shinzo Abe: concern in Japan after second hospital visit in a week
Refusal to discuss health details fuels speculation PM may have to curtail term …
Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone
Takeda Pharmaceutical Co said on Monday it has agreed to sell its Japanese consumer healthcare business to U.S. investment fund Blackstone Group.
Blackstone Makes $2.3 Billion Deal for Japan Drug Business
Blackstone Group is buying the consumer health-care business of Japan’s Takeda Pharmaceutical for $2.3 billion, one of the larger private-equity acquisitions in a country where such deals are slowly …